Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood tests may help predict recovery in rare brain clot condition

NCT ID NCT02013635

Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 232 people with cerebral venous thrombosis, a rare stroke that mainly affects young women. Researchers took blood samples at several time points to measure markers of clot formation and breakdown. They wanted to see if these markers relate to how the disease starts, its symptoms, or recovery. This is an observational study, not a test of a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

232 people

The number who actually took part.

Start date

Jul 2011

Finished

Sep 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over 16 years old hospitalized with an acute cerebral venous thrombosis, confirmed by by cerebral imaging

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral venous thrombosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral sinovenous thrombosis intracranial thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral venous thrombosis

Contacts and locations

Locations

  • C.H. François Quesnay

    Mantes-la-Jolie, 78201, France

  • C.H. Saint-Denis

    Saint-Denis, 33205, France

  • C.H. Yves Le Foll

    Saint-Brieuc, 22027, France

  • C.H. de Compiègne

    Compiègne, 60321, France

  • C.H. de La Rochelle

    La Rochelle, 17019, France

  • C.H. de Meaux

    Meaux, 77108, France

  • C.H. de Perpignan - Hôpital Saint-Jean

    Perpignan, 66046, France

  • C.H. de Versailles

    Le Chesnay, 78150, France

  • C.H.I. Eure-Seine

    Évreux, 27000, France

  • C.H.U de Poitiers

    Poitiers, 86021, France

  • C.H.U de Strasbourg

    Strasbourg, 67098, France

  • C.H.U. Limoges

    Limoges, 87042, France

  • C.H.U. de Grenoble

    Grenoble, 38043, France

  • CH Côte Basque

    Bayonne, 64100, France

  • CHI de Poissy- site de Poissy

    Poissy, 78300, France

  • CHRU Bretonneau

    Tours, 37000, France

  • CHU Estaing

    Clermont-Ferrand, 63003, France

  • CHU hopitaux de rouen

    Rouen, 76000, France

  • CHU-Hôpital Général

    Dijon, 21033, France

  • Ch Victor Dupouy

    Argenteuil, 95107, France

  • Chu Amiens

    Amiens, 80054, France

  • Chu D' Angers

    Angers, 49933, France

  • G.H. Paris Saint-Joseph

    Paris, 75014, France

  • G.H.U. Carémeau

    Nîmes, 30029, France

  • GH Pitié-Salpêtrière

    Paris, 75651, France

  • Hôpital Côte de Nacre

    Caen, 14033, France

  • Hôpital Guy de Chauliac

    Montpellier, 34295, France

  • Hôpital Henri Mondor

    Créteil, 94010, France

  • Hôpital J. Monod

    Le Havre, 76083, France

  • Hôpital Jean Minjioz

    Besançon, 25030, France

  • Hôpital Neurologique de Lyon

    Bron, 69677, France

  • Hôpital Nord de Laënnec

    Nantes, 44093, France

  • Hôpital Pellegrin - CHU Bordeaux

    Bordeaux, 33076, France

  • Hôpital de la Cavale Blanche

    Brest, 29609, France

  • Hôpital de la Timone

    Marseille, 13385, France

  • Hôpitaux Civils de Colmar

    Colmar, 68024, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.